The goals of the Data Analysis Core (DAC) are to provide cutting-edge analytical techniques to Coreinvestigators, to supply centralized data management methods to meld new experimental data with existingand evolving genetic and clinical information, to promote and facilitate the research undertaken by theCenter Investigators in the Oklahoma Rheumatic Disease Research Core Center (ORDRCC), and to provideeducational and technical support for the development of analytical capabilities at all levels of the ORDCC,spanning from established investigators to junior investigators and including post-doctoral candidates,students and select technical personnel. As potential collaborators for all research projects and keymandatory resources for all funded feasibility projects, the DAC will be an integral part of the research teamin study development and methodology selection, as well as providing ongoing statistical and analyticaladvice for each individual project. Centralized analysis through the DAC will enable the development ofstandard operating procedures for data handling such as the standardization of statistical diagnostic checksof distributional assumptions, outliers (overly influential data points), to name a few. This will ensure that allanalyses are of the same high quality and rigor. The DAC provides more efficient management of the datashared between projects, better quality control of both data and analysis, improved transfer of data betweenCores and projects, and standardization of data and analysis presentation. The specific functions of the DACwill include providing state of the art analysis capabilities for data from SNP arrays, gene expression, geneticlinkage, genetic association studies and longitudinal data collections; providing experimental design adviceand training to Center Investigators (and to OMRF); assisting, advising, and implementing high quality datamanagement within laboratories; developing key new analytic methods for evolving data; and providing highlevel informatics and programming capabilities to Junior Investigators. Services offered by the DAC:consultation on experimental design including power analysis; genetics data analysis including linkage andassociation approaches, which further subdivide to include fine mapping methods, family-based associationand haplotype-based methods, case-control candidate gene methods and multi-locus methods; geneexpression analysis from microarray experiments including normalization of microarray data, analysis ofdifferentially expressed genes, analysis of alterations in gene functional association using various clusteringmethods, identifying genes associated with biochemical pathways of interest and creation of transcriptionbased gene networks, selection of genes with discriminatory capabilities for disease in genetic data analysisand basic statistical analysis. High quality data analysis provided by the DAC is essential for meaningfulinterpretation of results from proposed projects and for the planned collaborative interdisciplinary research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR053483-02
Application #
7673676
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2008-09-01
Project End
2012-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
2
Fiscal Year
2008
Total Cost
$139,425
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Bagavant, Harini; Dunkleberger, Micah L; Wolska, Nina et al. (2018) Antibodies to periodontogenic bacteria are associated with higher disease activity in lupus patients. Clin Exp Rheumatol :
Scofield, R Hal; Sharma, Rohan; Harris, Valerie M (2018) Reply. Arthritis Rheumatol 70:626-627
Glauzy, Salomé; Boccitto, Marco; Bannock, Jason M et al. (2018) Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjögren's Syndrome. Arthritis Rheumatol 70:298-307
St Clair, E William; Baer, Alan N; Wei, Chungwen et al. (2018) Clinical Efficacy and Safety of Baminercept, a Lymphotoxin ? Receptor Fusion Protein, in Primary Sjögren's Syndrome: Results From a Phase II Randomized, Double-Blind, Placebo-Controlled Trial. Arthritis Rheumatol 70:1470-1480
Martínez-Bueno, Manuel; Oparina, Nina; Dozmorov, Mikhail G et al. (2018) Trans-Ethnic Mapping of BANK1 Identifies Two Independent SLE-Risk Linkage Groups Enriched for Co-Transcriptional Splicing Marks. Int J Mol Sci 19:
Koelsch, Kristi A; Cavett, Joshua; Smith, Kenneth et al. (2018) Evidence of Alternative Modes of B Cell Activation Involving Acquired Fab Regions of N-Glycosylation in Antibody-Secreting Cells Infiltrating the Labial Salivary Glands of Patients With Sjögren's Syndrome. Arthritis Rheumatol 70:1102-1113
LaBryer, Lauren; Sharma, Rohan; Chaudhari, Kaustubh Suresh et al. (2018) Kratom, an Emerging Drug of Abuse, Raises Prolactin and Causes Secondary Hypogonadism: Case Report. J Investig Med High Impact Case Rep 6:2324709618765022
Hinks, Anne; Marion, Miranda C; Cobb, Joanna et al. (2018) Brief Report: The Genetic Profile of Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis Resembles That of Adult Rheumatoid Arthritis. Arthritis Rheumatol 70:957-962
Karp, David R; Chong, Benjamin F; James, Judith A et al. (2018) Mock Recruitment for the Study of Antimalarials in Incomplete Lupus Erythematosus Trial. Arthritis Care Res (Hoboken) :
Pelikan, Richard C; Kelly, Jennifer A; Fu, Yao et al. (2018) Enhancer histone-QTLs are enriched on autoimmune risk haplotypes and influence gene expression within chromatin networks. Nat Commun 9:2905

Showing the most recent 10 out of 284 publications